Jayanthi, M (2012) Development and Validation of RP-HPLCMethod for Determination of Glibenclamide in Pharmaceutical Dosage Forms. International Journal of ChemTech Research, 4 (2). pp. 593-601. ISSN 0974-4290

[thumbnail of Development_and_Validation_of_RP-HPLC_Method_for_D.pdf] Text
Development_and_Validation_of_RP-HPLC_Method_for_D.pdf - Published Version
Download (489kB)

Abstract

A rapid, linear, precise, selective and accurate reverse phase HPLC method was developed and validated for simultaneous estimation of glibenclamide in tablet dosage form. The method employed for analysis using methanol as a solvent.The wavelength UV 300 nm was selected for estimation and linearity was observed in the concentration range of 160 - 240 μg/ml for glibenclamide respectively. The recovery studies ascertained the accuracy of the proposed method and the results were validated as per ICH guidelines. The method can be employed for estimation of pharmaceutical dosage formulations with no interference from any other excipients and diluents. The resolution between the closest peaks glibenclamide was more than 1.5 gives a linear response
(r2>0.999). The method can be used for quality control assay of the bulk and finished dosage form as single component. Moreover, the method was estimated as per ICH guidelines and the results were found to be within the acceptable range. Hence, the proposed method can be used for the routine quality control of the drugs and can also be applied to stability of glibenclamide in pharmacokinetic studies.

Item Type: Article
Uncontrolled Keywords: Glibenclamide, Reverse phases HPLC, Validation.
Divisions: PSG College of Arts and Science > Department of Chemistry
Depositing User: Mr Team Mosys
Date Deposited: 21 Apr 2022 09:13
Last Modified: 21 Apr 2022 09:13
URI: http://ir.psgcas.ac.in/id/eprint/1161

Actions (login required)

View Item
View Item
Altmetric